From Pill to Chip: Small-Cap Pharma Company to Enter the High-Growth Semiconductor Industry with High ROE and ROCE!
From Pill to Chip:  Small-Cap Pharma Company to Enter the High-Growth Semiconductor Industry with High ROE and ROCE!

From Pill to Chip: Small-Cap Pharma Company to Enter the High-Growth Semiconductor Industry with High ROE and ROCE!

An ace investor, Ashish Kacholia holds 2.13 per cent stake in in the company, aggregating to Rs 83.71 crore.

Kiran Shroff Article rating: 4.0

An ace investor, Ashish Kacholia holds 2.13 per cent stake in in the company, aggregating to Rs 83.71 crore.

Stock below Rs 1: Shares of this small-cap company zoom 62 per cent in just 5 days as it announces rights issue!
Stock below Rs 1: Shares of this small-cap company zoom 62 per cent in just 5 days as it announces rights issue!

Stock below Rs 1: Shares of this small-cap company zoom 62 per cent in just 5 days as it announces rights issue!

The main Indian indices ended the day higher on Friday, BSE Sensex was up 1.78 per cent at a level of 58,991.52.

Kiran Shroff Article rating: 3.9

The main Indian indices ended the day higher on Friday, BSE Sensex was up 1.78 per cent at a level of 58,991.52.

Low PE high ROE multibagger stock: This small-cap company has been declared as an L-1 bidder for an order worth Rs 655.099 crore!
Low PE high ROE multibagger stock: This small-cap company has been declared as an L-1 bidder for an order worth Rs 655.099 crore!

Low PE high ROE multibagger stock: This small-cap company has been declared as an L-1 bidder for an order worth Rs 655.099 crore!

The stock gave multibagger returns of 192 per cent in just 2 years with a PE of 13.71x whereas the industry PE is 33.22x and ROE of 30.51 per cent

Kiran Shroff Article rating: 4.7

The stock gave multibagger returns of 192 per cent in just 2 years with a PE of 13.71x whereas the industry PE is 33.22x and ROE of 30.51 per cent

Don’t miss action in this stock that has announced rights issue!
Don’t miss action in this stock that has announced rights issue!

Don’t miss action in this stock that has announced rights issue!

In FY22, net sales rose by 27.48 per cent over FY21. In FY22, the company reported a net profit of Rs 14 crore compared to a net loss of Rs 103 crore in FY21.  

Kiran Shroff Article rating: 4.6

In FY22, net sales rose by 27.48 per cent over FY21. In FY22, the company reported a net profit of Rs 14 crore compared to a net loss of Rs 103 crore in FY21.  

DSIJ MINDSHARE

Mkt Commentary3-Oct, 2023

Penny Stocks3-Oct, 2023

Mindshare3-Oct, 2023

Mindshare3-Oct, 2023

Bonus and Spilt Shares3-Oct, 2023

Knowledge

General30-Sep, 2023

General26-Sep, 2023

Technical25-Sep, 2023

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Investment in securities market are subject to market risks.Read all the related documents carefully before investing.
Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.